Impact of COVID-19 and Inflammatory Bowel Disease
July 7, 2021
Get highlights from the Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada report. Experts and co-authors of the report review the epidemiology of COVID-19 in Canada; risk factors for persons with IBD and medications; the impact of COVID-19 in children, families, seniors, and pregnant people with IBD; mental health and wellness; vaccines; healthcare services; and future policy implications.
Click here to download a PDF of the 2021 Impact of COVID-19 and IBD in Canada report.
Dr. Lesley Graff (PhD, Cpsych), Clinical Health Psychologist, Department Head, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba
Dr. Charles Bernstein (MD, FRCPC), Distinguished Professor of Medicine Head, Section of Gastroenterology, Program Director of the Gastroenterology Postgraduate Training Program, Director of the Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba
Dr. Ellen Kuenzig (PhD), Senior Research Associate, Epidemiologist, Inflammatory Bowel Disease Centre, SickKids Hospital, Person living with IBD
Dr. Cynthia Seow (MBBS, MSc, FRACP), Pregnancy and IBD Specialist, Associate Professor, Division of Gastroenterology and Hepatology, Departments of Medicine and Community Health Sciences, University of Calgary
Dr. Laura Targownik (MD, MSHS, FRCPC), Associate Professor of Medicine Departmental Division Director (Gastroenterology), University of Toronto Chair for Diversity and Equity, Canadian Association of Gastroenterology Staff Gastroenterologist, Mount Sinai Hospital
Dr. Deanna Gibson (PhD), Associate Professor, Biology, University of British Columbia, Okanagan Campus
Dr. Joseph Windsor (PhD), Research Associate, Medicine, Knowledge Translator, Inflammatory Bowel Disease Unit, University of Calgary
Dr. Sanjay Murthy (MD, FRCPC), Assistant Professor, Medicine, Clinician Investigator, Division of Gastroenterology, Associate Scientist in the Clinical Epidemiology Program, Ottawa Hospital Research Institute, University of Ottawa, Member of the Ottawa Hospital IBD Centre
Dr. Stephanie Coward (PhD), Research Associate, Medicine, Epidemiologist, Inflammatory Bowe Disease Unit, University of Calgary
Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist and Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary, Past Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada l Twitter: @gilkaplan
Dr. Eric Benchimol (MD, PhD, FRCPC), Professor, Pediatric Gastroenterologist, Department of Paediatrics, The Hospital for Sick Children (SickKids) and University of Toronto, Division of Gastroenterology, Hepatology and Nutrition, SickKids, NASPGHAN Canadian Councilor, Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada | Twitter: @ericbenchimol
Want to help boost our research initiatives?
Text CURE to 20222 to donate $25 to Crohn’s and Colitis Canada’s critical research projects.